Global mHealth Apps Industry

Global mHealth Apps Industry

  • April 2021 •
  • 186 pages •
  • Report ID: 6032195 •
  • Format: PDF
Abstract:
- Global mHealth Apps Market to Reach $251.6 Billion by 2027
- Amid the COVID-19 crisis, the global market for mHealth Apps estimated at US$25 Billion in the year 2020, is projected to reach a revised size of US$251.6 Billion by 2027, growing at a CAGR of 39.1% over the analysis period 2020-2027. Fitness, one of the segments analyzed in the report, is projected to record a 34.9% CAGR and reach US$68.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nutrition & Diet segment is readjusted to a revised 36.6% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 45.1% CAGR
- The mHealth Apps market in the U.S. is estimated at US$6.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$59.5 Billion by the year 2027 trailing a CAGR of 45.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 33.1% and 36.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 34.8% CAGR.
- Disease Management Segment to Record 38.9% CAGR
- In the global Disease Management segment, USA, Canada, Japan, China and Europe will drive the 37.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.8 Billion in the year 2020 will reach a projected size of US$26.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$38.7 Billion by the year 2027, while Latin America will expand at a 41% CAGR through the analysis period.

- Select Competitors (Total 36 Featured) -
  • Abbott Laboratories
  • Apple, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Fitbit, Inc.
  • GlaxoSmithKline plc
  • Jawbone Health Hub, Inc.
  • Johnson and Johnson
  • Livongo Health
  • Merck and Co., Inc.
  • Novartis AG
  • Omada Health, Inc.
  • Pfizer, Inc.
  • Sanofi